Skip to main content
. 2021 Sep 25;6(5):1228–1234. doi: 10.1002/lio2.667

FIGURE 2.

FIGURE 2

Characteristics of PGCCs. (A and B) Western blots of CD133, CyclinB1, CDC25C, EIF4A1, and CDK1 expression in TU212, cells after PTX withdrawal, as well as in PGCCs. (C and D) E‐cadherin and vimentin expression in TU212, cells after PTX withdrawal, as well as in PGCCs